Genexine Inc Capital Reinvestment Ratio

Latest as of March 2025: 4.87x

Genexine Inc capital reinvestment ratio. Genexine Inc (095700) has a Capital Reinvestment Ratio of 4.87x as of March 2025, meaning it reinvests 5% of its operating cash flow (₩799.82 Million) in capital expenditures (₩3.89 Billion). Check 095700 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

4.87x
Capex / Operating Cash Flow

Operating Cash Flow

₩799.82 Million
KRW

Capital Expenditures

₩3.89 Billion
KRW

Data as of

Mar 2025
Most recent filing

Capital Reinvestment Ratio of Genexine Inc (2009–2012)

Capital reinvestment ratio of Genexine Inc from 2009 to 2012. This chart tracks Genexine Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore Genexine Inc annual equity growth to track the company's year-over-year net asset growth rate.

Genexine Inc Capital Reinvestment Ratio by Year (2009–2012)

Genexine Inc capital reinvestment ratio by year from 2009 to 2012. For the full cash flow conversion analysis, see 095700 cash generation efficiency.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2012 1.45x ₩1.67 Billion ₩2.42 Billion ▼ -95.0%
2009 29.24x ₩35.23 Million ₩1.03 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow